These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27409729)

  • 1. Breast cancer imaging using radiolabelled somatostatin analogues.
    Dalm SU; Melis M; Emmering J; Kwekkeboom DJ; de Jong M
    Nucl Med Biol; 2016 Sep; 43(9):559-565. PubMed ID: 27409729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SSTR-Mediated Imaging in Breast Cancer: Is There a Role for Radiolabeled Somatostatin Receptor Antagonists?
    Dalm SU; Haeck J; Doeswijk GN; de Blois E; de Jong M; van Deurzen CHM
    J Nucl Med; 2017 Oct; 58(10):1609-1614. PubMed ID: 28450563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The somatostatin receptor family--a window against new diagnosis and therapy of cancer].
    Hofsli E
    Tidsskr Nor Laegeforen; 2002 Feb; 122(5):487-91. PubMed ID: 11961977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric PET imaging in thyroid malignancy characterizing tumour heterogeneity: somatostatin receptors and glucose metabolism.
    Traub-Weidinger T; Putzer D; von Guggenberg E; Dobrozemsky G; Nilica B; Kendler D; Bale R; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):1995-2001. PubMed ID: 26173620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo application of radiolabeled gastrin-releasing peptide receptor ligands in breast cancer.
    Dalm SU; Martens JW; Sieuwerts AM; van Deurzen CH; Koelewijn SJ; de Blois E; Maina T; Nock BA; Brunel L; Fehrentz JA; Martinez J; de Jong M; Melis M
    J Nucl Med; 2015 May; 56(5):752-7. PubMed ID: 25791989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues.
    Kaltsas GA; Papadogias D; Makras P; Grossman AB
    Endocr Relat Cancer; 2005 Dec; 12(4):683-99. PubMed ID: 16322317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individualized peptide-related-radionuclide-therapy concept using different radiolabelled somatostatin analogs in advanced cancer patients.
    Gabriel M; Andergassen U; Putzer D; Kroiss A; Waitz D; Von Guggenberg E; Kendler D; Virgolini IJ
    Q J Nucl Med Mol Imaging; 2010 Feb; 54(1):92-9. PubMed ID: 20168291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary neuroendocrine tumours and somatostatin receptor status: an assessment of unlicensed use of somatostatin analogues in the clinical practice.
    Kiesewetter B; Mazal P; Kretschmer-Chott E; Mayerhoefer ME; Raderer M
    ESMO Open; 2022 Jun; 7(3):100478. PubMed ID: 35525183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide Receptor Radionuclide Therapy (PRRT) of Medullary and Nonmedullary Thyroid Cancer Using Radiolabeled Somatostatin Analogues.
    Salavati A; Puranik A; Kulkarni HR; Budiawan H; Baum RP
    Semin Nucl Med; 2016 May; 46(3):215-24. PubMed ID: 27067502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 1--molecular pathways.
    Cakir M; Dworakowska D; Grossman A
    J Cell Mol Med; 2010 Nov; 14(11):2570-84. PubMed ID: 20629989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review: Receptor Targeted Nuclear Imaging of Breast Cancer.
    Dalm SU; Verzijlbergen JF; De Jong M
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin receptor scintigraphy in metastatic breast cancer patients.
    Mezi S; Primi F; Orsi E; Capoccetti F; Scopinaro F; Schillaci O
    Oncol Rep; 2005 Jan; 13(1):31-5. PubMed ID: 15583798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oestrogen-mediated regulation of somatostatin receptor expression in human breast cancer cell lines assessed with 99mTc-depreotide.
    Van Den Bossche B; D'haeninck E; De Vos F; Dierckx RA; Van Belle S; Bracke M; Van de Wiele C
    Eur J Nucl Med Mol Imaging; 2004 Jul; 31(7):1022-30. PubMed ID: 15029461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of technetium-99m-labeled octreotide acetate scintigraphy in suspected breast cancer and correlates with expression of SSTR.
    Wang F; Wang Z; Wu J; Qu W; Yao W; Zhao J; Liu Z
    Nucl Med Biol; 2008 Aug; 35(6):665-71. PubMed ID: 18678351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of somatostatin receptor subtypes in human pituitary adenomas -- immunohistochemical studies.
    Pisarek H; Pawlikowski M; Kunert-Radek J; Radek M
    Endokrynol Pol; 2009; 60(4):240-51. PubMed ID: 19753537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current knowledge on the sensitivity of the (68)Ga-somatostatin receptor positron emission tomography and the SUVmax reference range for management of pancreatic neuroendocrine tumours.
    Virgolini I; Gabriel M; Kroiss A; von Guggenberg E; Prommegger R; Warwitz B; Nilica B; Roig LG; Rodrigues M; Uprimny C
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2072-83. PubMed ID: 27174220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin analogs and radiopeptides in cancer therapy.
    Froidevaux S; Eberle AN
    Biopolymers; 2002; 66(3):161-83. PubMed ID: 12385036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast Cancer.
    Dalm SU; Schrijver WA; Sieuwerts AM; Look MP; Ziel-van der Made AC; de Weerd V; Martens JW; van Diest PJ; de Jong M; van Deurzen CH
    PLoS One; 2017; 12(1):e0170536. PubMed ID: 28107508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours.
    Modlin IM; Pavel M; Kidd M; Gustafsson BI
    Aliment Pharmacol Ther; 2010 Jan; 31(2):169-88. PubMed ID: 19845567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin receptor profiling in hepatic metastases from small intestinal and pancreatic neuroendocrine neoplasms: immunohistochemical approach with potential clinical utility.
    Nasir A; Stridsberg M; Strosberg J; Su PH; Livingston S; Malik HA; Kelley ST; Centeno BA; Coppola D; Malafa ME; Yeatman TJ; Kvols LK
    Cancer Control; 2006 Jan; 13(1):52-60. PubMed ID: 16508627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.